Simpler Grants.gov #HT942526ARPCTA

FY26 Autism Research Program Clinical Trial Award – Research Services Solicitation

The Department of the Army and Defense Health Agency are soliciting applications for the FY26 Autism Research Program Clinical Trial Award, supporting research to advance autism treatment and management. - Government Buyer: - Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA) - Defense Health Agency, Defense Health Agency Research and Development (DHA R&D), Defense Health Agency Contracting Activity (DHACA) - Products/Services Requested: - Clinical trial research services focused on autism, including evaluation of new drugs, biologics, devices, clinical guidance, or emerging technologies - Projects may range from small proof-of-concept studies to large-scale efficacy trials - No specific OEMs or vendors are named, as the solicitation funds research proposals rather than procurement of defined products - Unique or Notable Requirements: - Mandatory collaboration with community members (e.g., autistic individuals, caregivers, or community organizations) throughout the research process - Partnering Principal Investigator (PI) option available to support early-career investigators, with mentorship requirements - Applicants must demonstrate access to suitable patient populations for clinical trials - No cost sharing or matching required - Open to all eligible applicants without restriction - Funding and Award Details: - Maximum funding available is $3,250,000 (Army) and up to $1,750,000 (DHA) over a maximum period of performance of four years - Anticipated single award per agency

Description

The fiscal year 2026 (FY26) Autism Research Program (ARP) Clinical Trial Award supports the rapid implementation of clinical trials aimed at significantly impacting the treatment or management of autism. Clinical trials may evaluate new products, pharmacologic agents, devices, clinical guidance, or emerging technologies, ranging from small proof-of-concept trials to large-scale efficacy trials in relevant patient populations. Applications are encouraged to address specific FY26 ARP Clinical Trial Award Areas of Interest and must include community collaborations to optimize research impact. The award offers a partnering principal investigator option to support early-career investigators in autism clinical trial research.

View original listing